GE HealthCare Technologies Inc Common Stock (GEHC)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$70.01
Buy
$70.44
$-1.63 (-2.26%)
Prices updated at 03 Apr 2026, 00:34 EDT
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. H. Lawrence Culp, Jr
CEO
Mr. Peter J. Arduini
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
54,000
Head office
500 West Monroe Street
Chicago
United States
60661
Key personnel
Owner name | Salary |
|---|---|
Mr. Kevin A. Lobo Director | - |
Dr. Risa Lavizzo-Mourey Lead Independent Director | 0.18m |
Dr. Tomislav Mihaljevic Independent Director | 0.13m |
Ms. Catherine A. Lesjak Independent Director | 0.15m |
Mr. H. Lawrence Culp, Jr Chairman of the Board | 0.25m |
Mr. Peter J. Arduini President, Chief Executive Officer and Director | 1.32m |
Mr. William J. Stromberg Independent Director | 0.14m |
Mr. Frank R. Jimenez General Counsel and Corporate Secretary | 0.89m |
Dr. Rodney F. Hochman, M.D. Independent Director | 0.12m |
Mr. James K. Saccaro Vice President and Chief Financial Officer | 0.89m |
Ms. Anne T. Madden Independent Director | 0.12m |
Ms. Jeannette Bankes President and Chief Executive Officer, Patient Care Solutions | 0.44m |
Ms. Phoebe L. Yang Independent Director | 0.13m |
Mr. Adam Y. Holton Chief People Officer | - |
Mr. Kevin M. O’Neill President and Chief Executive Officer, Pharmaceutical Diagnostics | - |
Mr. Roland Rott President and Chief Executive Officer, Imaging | - |
Mr. George A. Newcomb Chief Accounting Officer | - |
Dr. Taha Kass-Hout, M.D.,M.S. Chief Science and Technology Officer | 0.90m |
Mr. Philip Rackliffe President and Chief Executive Officer, Advanced Visualization Solutions | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 52,275,767 |
| BlackRock Inc | 36,548,498 |
| Dodge & Cox | 31,211,229 |
| Capital Research Global Investors | 25,362,352 |
| Capital Research and Management Company | 24,849,587 |
Director dealings
Date | Action |
|---|---|
| 11 Sep 2025 | - |
| 11 Sep 2025 | - |
| 11 Sep 2025 | - |
| 11 Sep 2025 | - |
| 11 Sep 2025 | - |
| 11 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
| 01 Sep 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
